Loading Alembic Pharmaceuticals…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | 2,150 | 1,848 | 1,876 | 1,711 | 1,770 |
| Operating profit | 234 | 139 | 213 | 208 | 203 |
| Operating margin | 10.9% | 7.5% | 11.4% | 12.1% | 11.5% |
| Net profit | 173 | 203 | 133 | 154 | 157 |
| Net margin | 8.1% | 11.0% | 7.1% | 9.0% | 8.9% |
| EPS (₹) | 8.80 | 10.31 | 6.76 | 7.85 | 7.98 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 7,213 | 6,540 | 6,112 | 5,500 |
| Operating profit | 804 | 735 | 664 | 444 |
| Operating margin | 11.1% | 11.2% | 10.9% | 8.1% |
| Net profit | 675 | 583 | 616 | 342 |
| Net margin | 9.4% | 8.9% | 10.1% | 6.2% |
| EPS (₹) | 34.33 | 29.68 | 31.33 | 17.40 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 8,763 | 7,773 | 6,446 | 6,183 |
| Total liabilities | 3,094 | 2,583 | 1,627 | 1,812 |
| Shareholders’ equity | 5,675 | 5,191 | 4,818 | 4,370 |
| Total debt | 1,430 | 1,258 | 513 | 722 |
| Cash & equivalents | 196 | 83 | 120 | 75 |
| Debt / equity | 0.25 | 0.24 | 0.11 | 0.17 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 783 | 88 | 803 | 724 |
| Capital expenditure | -495 | -564 | -327 | -443 |
| Free cash flow | 288 | -476 | 476 | 281 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 11.9% | 11.2% | 12.8% | 7.8% |
| Return on assets | 7.7% | 7.5% | 9.6% | 5.5% |
| Net margin | 9.4% | 8.9% | 10.1% | 6.2% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for APLLTD. Finnhub coverage is limited for some India-listed stocks.